Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
第一著者: | Moreino, Shannon Sherwin |
---|---|
その他の著者: | Kabir, Eva Rahman |
フォーマット: | Project report |
言語: | English |
出版事項: |
BRAC University
2018
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/9331 |
類似資料
-
Biologics and Biosimilars as Treatment Options for Psoriasis
著者:: Moya, Amena Khatun
出版事項: (2023) -
Biosimilar in lymphoma treatment
著者:: Tanisha, Mehrin Haque
出版事項: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
著者:: Tabassum, Turana
出版事項: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
著者:: Tania, Umme
出版事項: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
著者:: Tania, Umme
出版事項: (2023)